Adgero Biopharmaceuticals Holdings
New York, US · Founded 2015
Founders & leadership
JB
John BrancaccioExecutive Officer
DH
David HochmanExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$459KraisedSep 2016 · 21 investors · Biotechnology
Rule 506(b)$3MraisedApr 2016 · 39 investors · Biotechnology
Rule 506(b)$39.8KraisedNov 2015 · 9 investors · Investing
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.